The National Institutes of Health has awarded a University System of Maryland institute a $6 million grant to develop a vaccine for the hepatitis C virus.
The Institute for Bioscience and Biotechnology Research will conduct the grant-funded research over a five-year period. The institute is a joint research enterprise between the University of Maryland, College Park, the University of Maryland, Baltimore and the National Institute of Standards and Technology.
The University of Virginia’s Board of Visitors on Friday approved an academic affiliation with the Inova Health System Foundation that includes a research institute and a UVA School of Medicine regional campus.
Global Genomics and Bioinformatics Research Institute UVA and Inova, along with partner George Mason University, will recruit investigators to work in collaborative teams on genetics and genomics, bioengineering, systems biology of disease, developmental biology and computational biology. The goal: make scientific discoveries that can be turned into new treatments, drugs and devices that improve the health of patients across Virginia and beyond.
Few issues are more foundational to driving improvements in human health than creating productive, progressive relationships between clinical medicine and the biopharmaceutical industry. The big public health problems that humanity faces today — including Alzheimer’s disease, cancer, and metabolic and infectious disease — will not be solved by either sector working in a silo. But the interface between the two has never been more tense. Legitimate concerns over conflict of interest that have resulted in overly extreme preventative policies are a central cause. It is time for all parties to revisit those policies and replace them with rules that recognize both true conflicts and true confluences of interest. They are essential to forging the strong collaborations that are worthy of society’s trust.
Crowdfunding platforms such as GoFundMe and YouCaring have turned sympathy for Americans drowning in medical expenses into a cottage industry. Now Republican efforts in Congress to repeal and replace Obamacare could swell the ranks of the uninsured and spur the business of helping people raise donations online to pay for health care.
But medical crowdfunding doesn’t have to wait for Congress to act. Business is already booming, and its leaders expect the rapid growth to continue no matter what happens on the Hill.
President Trump has named Norman “Ned” Sharpless, the director of the University of North Carolina Lineberger Comprehensive Cancer Center, to lead the National Cancer Institute.
The oncologist and geneticist will succeed Doug Lowy, who has been acting director of NCI since early 2015. Lowy is expected to remain at the institute as deputy director and a researcher.
Johns Hopkins University is among the top ten institutions worldwide to receive U.S. utility patents in 2016, according to a rankings report published by the National Academy of Inventors and the Intellectual Property Owners Association. The report ranks JHU at No. 7, with the university listed as the first assignee on 167 patents issued by the U.S. Patent and Trademark Office last year.
A program at the University of Virginia’s College at Wise aimed to bolster economic development in the region has received millions to help more students and the community get involved.
The Wise County school announced Friday that their parent school in Charlottesville has allocated $3.5 million from its Strategic Fund for the Wise Innovation Ecosystem.
German research company Qiagen has announced its expansion in Thailand and has opened an office in Bangkok to enhance relationships with life-science researchers and healthcare providers in this growing market.
Qiagen also announced two new collaborations in Thailand: a molecular techniques centre established with the faculty of tropical medicine at Mahidol University, and a collaboration with Ramathibodi Hospital to study genomic insights from next-generation sequencing (NGS).
Johns Hopkins University has been ranked among the top 2 percent of universities in the world by the 2018 QS World University Rankings released today.
Out of 950 universities from more than 80 countries, Johns Hopkins came in at No. 17—the same ranking as last year—and was the ninth-highest ranked U.S. school. QS has ranked JHU among the world’s top 20 universities for the past ten years, and among the top 30 since the rankings list debuted in 2004.
There’s no shame in getting a little bit of help, particularly when it comes to running a business. Sure, you can bootstrap a one-man company with no advice from seasoned entrepreneurs and a notable lack of experience yourself, but you know what’s going to happen? You’re probably going to fail. And all you had to do was ask for a little bit of guidance for your friendly neighborhood startup accelerator.
Can they do whatever a spider can? Definitely not. But what they can do is provide you with capital, mentorship, and perhaps most importantly, a little structure to your budding business. A startup accelerator is designed to make life as an entrepreneur easier. Well, the good ones are anyway.
